Menu
Currency
GWAS Study

Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women.

Chung J, Das A, Sun X et al.

35770850 PubMed ID
GWAS Study Type
10340 Participants
44 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CJ
Chung J
DA
Das A
SX
Sun X
SD
Sobreira DR
LY
Leung YY
IC
Igartua C
MS
Mozaffari S
CY
Chou YF
TS
Thiagalingam S
MJ
Mez J
ZX
Zhang X
JG
Jun GR
ST
Stein TD
KB
Kunkle BW
ME
Martin ER
PM
Pericak-Vance MA
MR
Mayeux R
HJ
Haines JL
SG
Schellenberg GD
NM
Nobrega MA
LK
Lunetta KL
PJ
Pinto JM
WL
Wang LS
OC
Ober C
FL
Farrer LA
Chapter II

Abstract

Summary of the research findings

Introduction: Variants in the tau gene (MAPT) region are associated with breast cancer in women and Alzheimer's disease (AD) among persons lacking apolipoprotein E ε4 (ε4-).

3,399 European ancestry female cases, 6,905 European ancestry female controls

Chapter III

Study Statistics

Key metrics and study information

10340
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.